Finance

Lists
KZIA:NASDAQ
Kazia Therapeutics Ltd
12,26 US$
-5,98%
(-0,78) 1D
24 ივლ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KZIA...
Open
13,04 US$
High
13,38 US$
Low
12,03 US$
Mkt. cap
131,58 მლნ.
Avg. vol.
172,43 ათ.
Volume
317,98 ათ.
52-wk high
17,40 US$
52-wk low
4,86 US$
EPS
-6,34 US$
Beta
2,54
Shares outstanding
11,34 მლნ.
No. of employees
6
Open
13,04 US$
High
13,38 US$
Low
12,03 US$
Mkt. cap
131,58 მლნ.
Avg. vol.
172,43 ათ.
Volume
317,98 ათ.
52-wk high
17,40 US$
52-wk low
4,86 US$
EPS
-6,34 US$
Beta
2,54
Shares outstanding
11,34 მლნ.
No. of employees
6
News stories
From sources across the web
About Kazia Therapeutics Ltd
CEO-
Employees6
Founded1994
Headquarters-
Sector-
Websitekaziatherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to KZIA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for KZIA in the last 3 months.
Highest
Current 12,26 US$
34,00 US$ (+177,32%)
Average
28,50 US$ (+132,46%)
Lowest
18,00 US$ (+46,82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
30,00 US$
+144,7%
07/15/2026
Kambiz Yazdi
BTIG
Buy
Maintained
34,00 US$
+177,3%
07/15/2026
Chad Messer
Lake Street
Buy
Initiated
32,00 US$
+161%
06/11/2026
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
18,00 US$
+46,8%
06/04/2026
Yale Jen
Laidlaw
Buy
Initiated
25,00 US$
+103,9%
04/15/2026
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
903,36 ათ.
903,36 ათ.
45,96 ათ.
45,96 ათ.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,52 მლნ.
1,52 მლნ.
2,50 მლნ.
2,50 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,81 მლნ.
1,81 მლნ.
4,28 მლნ.
4,28 მლნ.
Operating expense
3,33 მლნ.
3,33 მლნ.
6,78 მლნ.
6,78 მლნ.
Total operating expenses
3,33 მლნ.
3,33 მლნ.
6,78 მლნ.
6,78 მლნ.
Operating income
-2,42 მლნ.
-2,42 მლნ.
-6,73 მლნ.
-6,73 მლნ.
Other non operating income
-239,18 ათ.
-239,18 ათ.
372,46 ათ.
372,46 ათ.
EBT including unusual items
-5,93 მლნ.
-5,93 მლნ.
-6,28 მლნ.
-6,28 მლნ.
EBT excluding unusual items
-2,64 მლნ.
-2,64 მლნ.
-6,28 მლნ.
-6,28 მლნ.
Income tax expense
-805,23 ათ.
-805,23 ათ.
-
-
Effective tax rate
13,58%
13,58%
-
-
Other operating expenses
-
-
-
-
Net income
-5,12 მლნ.
-5,12 მლნ.
-6,28 მლნ.
-6,28 მლნ.
Net profit margin
-567,23%
-567,23%
-13 655,59%
-13 655,59%
Earnings per share
-
-
-
-
Interest and investment income
21,67 ათ.
21,67 ათ.
80,46 ათ.
80,46 ათ.
Interest expense
-
-
-
-
Net interest expenses
21,67 ათ.
21,67 ათ.
80,46 ათ.
80,46 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,11 მლნ.
-2,19 მლნ.
-6,50 მლნ.
-6,50 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer